1

Apr 26

Brain

Wed 1st April 2026, 01:00pm
Online

Register Here

The Gut ID Clinical Education Series

Part 3 of a free 3-part online course for healthcare professionals


The final session in the series brings everything together through advanced, case-based learning, focusing on complex and multi-system presentations commonly seen in practice.

This free course continues with a further sessions, each building on the foundations established in Session 1 and moving progressively deeper into interpretation, intervention, and complex clinical application. Session 3 – Advanced & Complex Clinical Applications  1st April 2026, 1:00 – 3:00 pm (UK).

 

This advanced session will explore:

  • Complex case studies in neurodegenerative conditions

  • Microbiome and gut–brain considerations in cancer

  • Advanced applications in autoimmune disorders

  • Integrating gut, brain, immune, and metabolic drivers in treatment-resistant cases

This education series is supported by Gut ID, an advanced gut microbiome testing platform combining DNA sequencing with AI-powered analysis to support deeper clinical insight. The focus of this session is on how and when microbiome data should be used responsibly in clinical practice, helping practitioners build confidence in interpretation and clinical decision-making.

There will be Q&A sessions incorporated into all 3 parts of the education series.

Speaker

Elena Panzeri, MSc, BSc

Microbiome and Nutrigenomics Expert

Elena Panzeri holds an MSc (Master of Science) in Nutrition and Genetics a BSc (Bachelor of Science) in Nutritional Therapy along with advanced qualifications in naturopathy and homeopathy.. She has over 25 years of clinical experience in natural medicine and highly personalized nutrition. Her primary expertise lies in Personalized and Functional Medicine Nutrition, including nutrigenetics, epigenetics, microbiome analysis, metabolomics, and advanced functional medicine testing. She is currently investigating the link between gut and oral microbiome and neurodegenerative disorders such as Alzheimer’s and Parkinson’s. In parallel, she consults for Intus Biosciences, contributing to the clinical development of advanced microbiome testing and interpreting hundreds of complex patient profiles worldwide.